Clinical Trial Update: Eflornithine and Sulindac in Preventing Colorectal Cancer in Patients With Colon Polyps [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating eflornithine and sulindac to prevent colorectal cancer in patients with colon polyps; status is completed and results were posted in 20…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Polyps
• Colorectal Cancer

Drugs mentioned

• Eflornithine (eflornithine)
• Sulindac (sulindac)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Precancerous Condition | Phase 3 | Status: COMPLETED | Results posted: 2015-01-22